Approved in Europe: There is a vaccine against monkeypox

0


After confirming 16 thousand cases of monkey pox Only in Europe, the World Health Organization (WHO) declared the highest level of alert, which triggered the extension, by the European Commission, of a vaccine to stop the increase in the disease.

“This approval of the monkeypox vaccine is an example of good cooperation between Bavarian Nordic and European regulators, an extension of employment that typically takes six to nine months,” the Danish manufacturer said in a statement.

The vaccine called Imvanex is the only formulation that has been approved for the prevention of monkeypox in the United States and Canada., but until now “it had only been approved in Europe to treat human smallpox”, cited Milenio. In this way, the vaccine will be available for the 27 countries of the European Union.

how it spread

Monkeypox is an endemic disease in parts of countries such as Nigeria, but on April 29, 2022, the first case was detected in the United Kingdom. This was a British resident who developed symptoms of the disease after traveling to Nigeria. The patient returned to the United Kingdom on May 4 and represented the so-called zero case or index case.

Zoonotic disease is caused by a virus. A note from the United Nations portal indicates that it can be transmitted from animals to humans and can also be spread from person to person. “Interestingly, the disease is so named because it was detected in several apes in a laboratory in 1958. However, most of the animals susceptible to contracting the disease and then infecting people are rodents, such as the Gambian giant rats, the dormouse or prairie dogs.

The countries where this disease is endemic are: Benin, Cameroon, Central African Republic, Democratic Republic of Congo, Gabon, Ivory Coast, Liberia, Nigeria, Republic of Congo, Sierra Leone and South Sudan.

The symptoms

Monkeypox manifests with fever, severe headache, muscle aches, back pain, low energy, swollen lymph nodes, and skin rashes or lesions.

“The rash usually starts on the first or third day of the onset of the fever. The lesions can be flat or slightly raised, filled with transparent or yellowish fluid, which later form scabs, dry up and fall off,” the report states.

Although most cases tend to be mild and the rashes disappear on their own (the disease can last up to four weeks), there are risk groups such as children, the elderly or the immunosuppressed. In these cases, the disease can be fatal.

“The number of injuries in a person varies between a few and several thousand. The rash tends to appear on the face, the palms of the hands, and the soles of the feet. They can also be found in the mouth, genitals, and eyes.

Related content

Zimbabwe uses gold coins against inflation

See the most shocking images of the eruption of the Sakurajima volcano

Leave A Reply
1 2 3 4 5 6 7 8 9 1234 78 65 41 14 85 96 35